-
公开(公告)号:US11441128B2
公开(公告)日:2022-09-13
申请号:US15771973
申请日:2016-10-27
Applicant: Genomatica, Inc.
Inventor: Nelson R. Barton , Jingyi Li , Joseph R. Warner , Priti Pharkya
Abstract: Described herein are fusion proteins including methanol dehydrogenase (MeDH) and at least one other polypeptide such as 3-hexulose-6-phosphate dehydrogenase (HPS) or 6-phospho-3-hexuloisomerase (PHI), such as DHAS synthase or fructose-6-Phosphate aldolase or such as DHA synthase or DHA kinase. In a localized manner, the fusion protein can promote the conversion of methanol to formaldehyde and then to a ketose phosphate such as hexulose 6-phosphate or then to DHA and G3P. When expressed in cells, the fusion proteins can promote methanol uptake and rapid conversion to the ketose phosphate or to the DHA and D3P, which in turn can be used in a pathway for the production of a desired bioproduct. Beneficially, the rapid conversion to the ketose phosphate or to the DHA and G3P can avoid the undesirable accumulation of formaldehyde in the cell. Also described are engineered cells expressing the fusion protein, optionally include one or more additional metabolic pathway transgene(s), methanol metabolic pathway genes, target product pathway genes, cell culture compositions including the cells, methods for promoting production of the target product or intermediate thereof from the cells, compositions including the target product or intermediate, and products made from the target product or intermediate.
-
52.
公开(公告)号:US20220056488A1
公开(公告)日:2022-02-24
申请号:US17225034
申请日:2021-04-07
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Mark J. Burk
Abstract: The invention provides non-naturally occurring microbial organisms having a toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene pathway. The invention additionally provides methods of using such organisms to produce toluene, benzene, p-toluate, terephthalate, (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate, (2-hydroxy-4-oxobutoxy)phosphonate, benzoate, styrene, 2,4-pentadienoate, 3-butene-1ol or 1,3-butadiene.
-
公开(公告)号:US20220025411A1
公开(公告)日:2022-01-27
申请号:US17193914
申请日:2021-03-05
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Jun Sun , Robin E. Osterhout , Priti Pharkya
IPC: C12P5/02 , C12N15/52 , C07C11/16 , C08F136/06
Abstract: The invention provides non-naturally occurring microbial organisms having a butadiene pathway. The invention additionally provides methods of using such organisms to produce butadiene.
-
公开(公告)号:US20210363556A1
公开(公告)日:2021-11-25
申请号:US17120005
申请日:2020-12-11
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya , Mark J. Burk
IPC: C12P17/08 , C12N15/70 , C08G63/08 , C07D313/04 , C12N15/63 , C12P17/02 , C08G18/42 , C12N5/00 , C12N15/52
Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
-
公开(公告)号:US20210277426A1
公开(公告)日:2021-09-09
申请号:US16953050
申请日:2020-11-19
Applicant: Genomatica, Inc.
Inventor: Stephanie J. Culler , Nicholas Eakley , Kevin Gregory Hoff , Robin E. Osterhout , Priti Pharkya , Erik C. Ralph , Stephen J. Van Dien
Abstract: Disclosed are methods and engineered microorganisms that enhance or improve the production of crotyl alcohol. The engineered microorganisms include genetic modifications in alcohol dehydrogenase, alkene reductase or both enzymatic activities. By such genetic modifications, a crotyl alcohol production pathway is provided or improved.
-
公开(公告)号:US20210147883A1
公开(公告)日:2021-05-20
申请号:US16785510
申请日:2020-02-07
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Priti Pharkya , Tae Hoon Yang , Jungik Choi
IPC: C12P7/18 , C12N9/02 , C12N9/12 , C12N9/16 , C12N15/52 , C12N1/20 , C12N9/00 , C07K14/245 , C12P7/42 , C12N9/52 , C12N9/88
Abstract: The invention is directed to a non-naturally occurring microbial organism comprising a first attenuation of a succinyl-CoA synthetase or transferase and at least a second attenuation of a succinyl-CoA converting enzyme or a gene encoding a succinate producing enzyme within a multi-step pathway having a net conversion of succinyl-CoA to succinate.
-
公开(公告)号:US20210108232A1
公开(公告)日:2021-04-15
申请号:US16884976
申请日:2020-05-27
Applicant: Genomatica, Inc.
Inventor: Jun Sun , Anthony P. Burgard , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a microbial organism having at least one exogenous gene insertion and/or one or more gene disruptions that confer production of primary alcohols. A method for producing long chain alcohols includes culturing these non-naturally occurring microbial organisms.
-
公开(公告)号:US20210040511A1
公开(公告)日:2021-02-11
申请号:US16997704
申请日:2020-08-19
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Mark J. Burk , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway. The invention additionally provides a method for producing 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid. The method can include culturing a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid producing microbial organism expressing at least one exogenous nucleic acid encoding a 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid pathway enzyme in a sufficient amount and culturing under conditions and for a sufficient period of time to produce 2-hydroxyisobutyric acid, 3-hydroxyisobutyric acid or methacrylic acid.
-
59.
公开(公告)号:US20190330670A1
公开(公告)日:2019-10-31
申请号:US16213671
申请日:2018-12-07
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.
-
公开(公告)号:US20190284592A1
公开(公告)日:2019-09-19
申请号:US16433804
申请日:2019-06-06
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya , Mark J. Burk
IPC: C12P17/08 , C12N15/52 , C12N5/00 , C08G63/08 , C07D313/04 , C12P17/02 , C12N15/70 , C12N15/63 , C08G18/42
Abstract: The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
-
-
-
-
-
-
-
-
-